Science
Science & Clinical Research
The research, evidence and intellectual property behind Lionheart’s bioelectric protein-expression platform.
Clinical Data Summary →
Reported clinical, pilot, observational and preliminary laboratory results by program, plus historical cardiac research.
Klotho-Up Wellness Study →
A 12-month, IRB-approved feasibility study of a combined approach to increasing circulating Klotho, focused on muscle, brain and immune health.
Protein & Signaling Targets →
The proteins and signaling targets Lionheart investigates, organized across 24 health areas.
Klotho Evidence →
Potential benefits of Klotho by health area, the type of evidence behind each, and 34 primary-study references.
Intellectual Property →
Issued, pending, in-process, licensed and optioned patents, and what the portfolio covers.
Regulatory →
FDA 510(k) clearances behind the platform, IRB-approved research and the commercialization strategy.
Technology explainers →
Bioelectric protein expression, Klotho therapy and encapsulated Klotho-expressing stem cells, in plain language.